Intelligent Bio Solutions adds Quantum TM, expanding fingerprint drug testing to 10 UK sites

INTELLIGENT BIO SOLUTIONS INC.

Quantum Traffic Management adopts INBS fingerprint drug screening across 10 UK sites, replacing saliva/urine methods.
INBS now serves over 400 accounts across 19 countries; plans US market entry in 2025.
INBS filed FDA 510(k) submission in December 2024 for US clearance.
Quantum TM's managing director highlights improved efficiency with in-house rapid testing.
Serves industries including construction, manufacturing, transport, and logistics.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.